These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 34334568)
1. A Long-term Persistent Vascular Fluorodeoxyglucose Uptake in a Patient with Large-vessel Vasculitis. Ie K; Sakai T; Kurosu E; Motohashi I; Yagihashi K; Okuse C; Matsuda T Intern Med; 2022 Feb; 61(3):357-360. PubMed ID: 34334568 [TBL] [Abstract][Full Text] [Related]
2. Imaging features of Chen Z; Zhao Y; Wang Q; Li Y; Li H; Zhou Y Clin Rheumatol; 2022 May; 41(5):1499-1509. PubMed ID: 35088208 [TBL] [Abstract][Full Text] [Related]
3. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit. Nguyen AD; Crowhurst T; Lester S; Dobson R; Bartholomeusz D; Hill C Int J Rheum Dis; 2019 Aug; 22(8):1378-1382. PubMed ID: 31211510 [TBL] [Abstract][Full Text] [Related]
4. [Positron emission tomography-CT scan (PET-CT) in the diagnosis of large vessel vasculitis]. Vicentela I A; Cifuentes J C; Barahona Z D; Chong M G; Schiappacasse F G Rev Med Chil; 2021 May; 149(5):773-778. PubMed ID: 34751331 [TBL] [Abstract][Full Text] [Related]
5. [18F-FDG PET in the diagnosis of large vessel vasculitis]. Rehák Z; Fojtík Z; Stanícek J; Bolcák K; Frysáková L Vnitr Lek; 2006 Nov; 52(11):1037-44. PubMed ID: 17165522 [TBL] [Abstract][Full Text] [Related]
7. JAK Inhibitor Effectiveness in Giant-Cell Arteritis With Large-Vessel Involvement Assessed by 18F-FDG PET-CT. Prigent K; Aouba A; Aide N; de Boysson H Clin Nucl Med; 2022 Mar; 47(3):234-235. PubMed ID: 34653043 [TBL] [Abstract][Full Text] [Related]
8. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039 [TBL] [Abstract][Full Text] [Related]
9. Association of Quinn KA; Ahlman MA; Alessi HD; LaValley MP; Neogi T; Marko J; Novakovich E; Grayson PC Arthritis Rheumatol; 2023 Jan; 75(1):98-107. PubMed ID: 35792044 [TBL] [Abstract][Full Text] [Related]
10. Imaging in large-vessel vasculitis. Schmidt WA; Nielsen BD Best Pract Res Clin Rheumatol; 2020 Dec; 34(6):101589. PubMed ID: 32948434 [TBL] [Abstract][Full Text] [Related]
11. PET-CT findings in large vessel vasculitis presenting as FUO, a case report. Akin E; Coen A; Momeni M Clin Rheumatol; 2009 Jun; 28(6):737-8. PubMed ID: 19242771 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis. Ince B; Işik EG; Özkan ZG; Yalçinkaya Y; Esen BA; Gül A; Inanç M Turk J Med Sci; 2024; 54(1):69-75. PubMed ID: 38812633 [TBL] [Abstract][Full Text] [Related]
13. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Galli E; Pipitone N; Salvarani C Curr Opin Rheumatol; 2023 May; 35(3):194-200. PubMed ID: 36866659 [TBL] [Abstract][Full Text] [Related]
14. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Walter MA Radiol Clin North Am; 2007 Jul; 45(4):735-44, viii. PubMed ID: 17706537 [TBL] [Abstract][Full Text] [Related]
15. PET/CT for Diagnosis and Management of Large-Vessel Vasculitis. Pelletier-Galarneau M; Ruddy TD Curr Cardiol Rep; 2019 Mar; 21(5):34. PubMed ID: 30887249 [TBL] [Abstract][Full Text] [Related]
16. Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides. Schäfer VS; Jin L; Schmidt WA Curr Rheumatol Rep; 2020 Sep; 22(11):76. PubMed ID: 32959107 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Prieto-González S; Depetris M; García-Martínez A; Espígol-Frigolé G; Tavera-Bahillo I; Corbera-Bellata M; Planas-Rigol E; Alba MA; Hernández-Rodríguez J; Grau JM; Lomeña F; Cid MC Ann Rheum Dis; 2014 Jul; 73(7):1388-92. PubMed ID: 24665112 [TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients. de Boysson H; Liozon E; Lambert M; Parienti JJ; Artigues N; Geffray L; Boutemy J; Ollivier Y; Maigné G; Ly K; Huglo D; Hachulla E; Hatron PY; Aouba A; Manrique A; Bienvenu B Medicine (Baltimore); 2016 Jun; 95(26):e3851. PubMed ID: 27367985 [TBL] [Abstract][Full Text] [Related]
19. Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently? de Boysson H; Liozon E; Lambert M; Dumont A; Boutemy J; Maigné G; Martin Silva N; Ly KH; Manrique A; Bienvenu B; Aouba A Am J Med; 2017 Aug; 130(8):992-995. PubMed ID: 28460851 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis. van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Sandovici M; Jamar F; Gheysens O; Slart RHJA Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3886-3902. PubMed ID: 33942141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]